We investigated the risk for contralateral breast cancer (CBC) associated with the CHEK2*1100delC germline mutation among approximately 2100 women with breast cancer who were cases and controls in the multicentre Women's Environment, Cancer and Radiation Epidemiology (WECARE) Study (Bernstein et al, 2004). Here, CHEK2 is linked to complete blood cell count.